U.S. Markets open in 7 hrs 9 mins

Clover Health Investments, Corp. (CLOV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.42-0.39 (-4.99%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close7.81
Open7.87
Bid0.00 x 1300
Ask0.00 x 4000
Day's Range7.41 - 7.87
52 Week Range6.31 - 17.45
Volume4,996,086
Avg. Volume16,583,291
Market Cap3.015B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.67
  • How Much Of Clover Health Investments, Corp. (NASDAQ:CLOV) Do Insiders Own?
    Simply Wall St.

    How Much Of Clover Health Investments, Corp. (NASDAQ:CLOV) Do Insiders Own?

    The big shareholder groups in Clover Health Investments, Corp. ( NASDAQ:CLOV ) have power over the company...

  • FINAL NOTICE: Kaskela Law LLC Announces Shareholder Class Action Lawsuit Against Clover Health Investments Corp. and Encourages Investors to Contact the Firm – CLOV, IPOC
    GlobeNewswire

    FINAL NOTICE: Kaskela Law LLC Announces Shareholder Class Action Lawsuit Against Clover Health Investments Corp. and Encourages Investors to Contact the Firm – CLOV, IPOC

    PHILADELPHIA, April 06, 2021 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that a shareholder class action lawsuit has been filed against Clover Health Investments Corp. (NASDAQ: CLOV) (“Clover” or the “Company”), formerly known as Social Capital Hedosophia Holdings Corp. III (NYSE: IPOC), on behalf of investors who purchased shares of the Company’s securities between October 6, 2020 and February 4, 2021, inclusive (the “Class Period”). Clover stockholders who purchased or acquired CLOV or IPOC securities securities prior to November 17, 2020 are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 – 1585, or by email at skaskela@kaskelalaw.com or online at https://kaskelalaw.com/case/clover/, for additional information about this action and their legal rights and options. As detailed in the complaint, on February 4, 2021, Hindenburg Research published a research report that revealed that Clover’s flagship platform, Clover Assistant, was the subject of a U.S. Department of Justice (“DOJ”) investigation for a variety of issues, including illegal kickbacks, marketing practices, and undisclosed related-party transactions. Hindenburg discovered that Clover’s sales growth was not driven by technology, but by deceptive sales practices. Following this news, Clover common stock fell $1.72 per share, or over 12% in value, to close on February 4, 2021 at $12.23 per share. The following day, Clover filed a Form 8-K disclosing that the SEC was conducting an “investigation and requesting document and data preservation for the period from January 1, 2020, to the present, relating to certain matters that are referenced in the [Hindenburg Research report].” Clover stockholders are encouraged to contact Kaskela Law LLC for additional information about this action. Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. CONTACT:D. Seamus Kaskela, Esq.KASKELA LAW LLC18 Campus Boulevard, Suite 100Newtown Square, PA 19073(484) 258 – 1585(888) 715 – 1740www.kaskelalaw.comskaskela@kaskelalaw.com This notice may constitute attorney advertising in certain jurisdictions.

  • SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Clover Health Investments, Corp. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 6, 2021 - CLOV
    Newsfile

    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Clover Health Investments, Corp. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 6, 2021 - CLOV

    New York, New York--(Newsfile Corp. - April 6, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Clover Health Investments, Corp. ("Clover") (NASDAQ: CLOV) between October 6, 2020 and February 3, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Middle District of Tennessee. To get ...